Cornerstone Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | $18.8M | Sell |
153,765
-316,583
| -67% | -$38.8M | 2.97% | 11 |
|
|
2016
Q2 | $54.9M | Buy |
470,348
+1,089
| +0.2% | +$127K | 2.9% | 14 |
|
|
2016
Q1 | $65.3M | Buy |
469,259
+114,870
| +32% | +$16M | 2.85% | 14 |
|
|
2015
Q4 | $67.6M | Sell |
354,389
-90,150
| -20% | -$17.2M | 2.76% | 13 |
|
|
2015
Q3 | $69.5M | Sell |
444,539
-62,949
| -12% | -$9.84M | 2.95% | 10 |
|
|
2015
Q2 | $91.7M | Buy |
507,488
+166,835
| +49% | +$30.2M | 3.01% | 9 |
|
|
2015
Q1 | $59M | Buy |
340,653
+109,046
| +47% | +$18.9M | 1.95% | 28 |
|
|
2014
Q4 | $42.9M | Sell |
231,607
-49,095
| -17% | -$9.08M | 1.39% | 35 |
|
|
2014
Q3 | $46.5M | Sell |
280,702
-15,257
| -5% | -$2.53M | 1.52% | 29 |
|
|
2014
Q2 | $46.2M | Buy |
295,959
+199,937
| +208% | +$31.2M | 1.48% | 32 |
|
|
2014
Q1 | $14.6M | Buy |
+96,022
| New | +$14.6M | 0.47% | 46 |
|